CITICLAV – 375
Advanced Antibiotic Combination for Effective Bacterial Infection Treatment
Citric Labs presents CITICLAV-375, a powerful antibiotic formulation containing Amoxycillin Trihydrate 250 mg and Clavulanic Potassium 125 mg. This combination is widely prescribed for the treatment of various bacterial infections affecting the respiratory tract, urinary tract, skin, soft tissues, ENT region, and more.
CITICLAV-375 works by stopping bacterial growth while Clavulanic Potassium helps overcome bacterial resistance, making the medicine more effective against resistant bacteria.
Composition
- Amoxycillin Trihydrate 250 mg
- Clavulanic Potassium 125 mg
Key Benefits
- Broad-spectrum antibacterial action
- Effective against resistant bacterial strains
- Helps treat respiratory and ENT infections
- Useful in urinary tract and skin infections
- Fast recovery with improved patient compliance
- Well-tolerated antibiotic combination
Product Description
CITICLAV-375 Tablets by Citric Labs contain Amoxycillin Trihydrate 250 mg and Clavulanic Potassium 125 mg, an effective antibiotic combination used for treating respiratory tract, ENT, urinary tract, skin, and bacterial infections. Trusted for its broad-spectrum antibacterial action, CITICLAV-375 is offered by Citric Labs with high-quality standards and excellent PCD Pharma Franchise support across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
